NexturnBioscience Co. Ltd (089140) — Financial Flexibility Index
NexturnBioscience Co. Ltd (089140) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of ₩4.80 Billion (operating CF ₩4.51 Billion minus capex ₩286.65 Million) represents 0% of total liabilities (₩128.65 Billion). Also explore NexturnBioscience Co. Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NexturnBioscience Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for NexturnBioscience Co. Ltd across 11 annual periods. Check 089140 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for NexturnBioscience Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for NexturnBioscience Co. Ltd. For the full company profile including market capitalisation, see NexturnBioscience Co. Ltd (089140) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.00x | ₩-412.57 Million | ₩-1.14 Billion | ₩96.41 Billion | ▲ +48.9% |
| 2023 | -0.01x | ₩-888.34 Million | ₩-1.97 Billion | ₩105.98 Billion | ▲ +15.1% |
| 2022 | -0.01x | ₩-908.42 Million | ₩-1.19 Billion | ₩91.98 Billion | ▼ -111.0% |
| 2021 | 0.09x | ₩4.13 Billion | ₩3.66 Billion | ₩46.21 Billion | ▼ -84.1% |
| 2020 | 0.56x | ₩1.45 Billion | ₩235.94 Million | ₩2.58 Billion | ▼ -86.7% |
| 2019 | 4.21x | ₩21.12 Billion | ₩2.74 Billion | ₩5.01 Billion | ▲ +672.4% |
| 2018 | 0.55x | ₩9.83 Billion | ₩9.63 Billion | ₩18.01 Billion | ▼ -72.6% |
| 2017 | 1.99x | ₩5.95 Billion | ₩5.08 Billion | ₩2.99 Billion | ▼ -8.3% |
| 2016 | 2.17x | ₩18.77 Billion | ₩17.88 Billion | ₩8.64 Billion | ▲ +143.8% |
| 2015 | 0.89x | ₩2.82 Billion | ₩1.92 Billion | ₩3.17 Billion | ▼ -39.5% |
| 2014 | 1.47x | ₩6.49 Billion | ₩6.48 Billion | ₩4.41 Billion | — |